NEW YORK (GenomeWeb News) — Compugen yesterday reported it earned no revenues for the second quarter of 2007, while R&D spending was down 15 percent and net loss was cut 11 percent.
 
The company reported $5,000 in revenue for the second quarter of 2006.           .
 
Compugen said R&D spending in the quarter dipped to $2.3 million from $2.7 million year over year.
 
Net loss was lowered slightly to $3.2 million from $3.6 million over the same quarter last year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.